Citation 120992

DE WITTE,P: AGOSTINIS,P: VAN LINT,J: MERLEVEDE,W: VANDENHEEDE,JR:. (1993). INHIBITION OF EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE ACTIVITY BY HYPERICIN.. 46(11)

Citation Details

Title	INHIBITION OF EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE ACTIVITY BY HYPERICIN.
Authors	DE WITTE,P: AGOSTINIS,P: VAN LINT,J: MERLEVEDE,W: VANDENHEEDE,JR:
Year	1993
Volume	46
Issue	11

Summary

Year: 1993

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYPERICIN	STRONG ACTIVITY
2	EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYPERICIN	STRONG ACTIVITY
3	CASEIN KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYPERICIN	INACTIVE
4	NUCLEOTIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYPERICIN	INACTIVE
5	PROTEIN KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYPERICIN	INACTIVE
6	PROTEIN KINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYPERICIN	ACTIVE
7	MYOSIN LIGHT CHAIN KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYPERICIN	WEAK ACTIVITY
8	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF COMPOUND - IN VITRO	HYPERICIN	ACTIVE
9	MONOAMINE OXIDASE INHIBITION(TYPE B)	PHARMACOLOGY OF COMPOUND - IN VITRO	HYPERICIN	ACTIVE
10	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYPERICIN	STRONG ACTIVITY
11	DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYPERICIN	ACTIVE
12	SUCCINATE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYPERICIN	ACTIVE
13	SUCCINATE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYPERICIN	ACTIVE

Show SPARQL Queries (1)